Delivery Order SPE2DB22D2206-SPE2DB25FJM65
Award Date 8/19/25
Potential Completion Date 9/10/25
Potential Value $42K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $13,851.75 delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Pomalyst 4 mg capsules (21-count units). This is a firm fixed-price, non-set-aside contract with performance scheduled for completion by August 29, 2025, and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- This federal contract award, valued at $36,698.28, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is for the delivery of POMALYST 3 MG CAPSULE 21S, a pharmaceutical product, with a completion date of May 14, 2024. AmerisourceBergen, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up...
- Amerisourcebergen Drug Corp has been awarded a firm fixed price delivery order against their indefinite delivery contract with the Defense Logistics Agency (DLA) Troop Support Medical. Valued at $12,084.50, this order is for the supply of 4562914807 POMALYST 4 MG CAPSULE 21S to support DLA medical facilities. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania, with completion by December 18, 2023. No set-aside designation was applied to this award. As a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $12,287.90 firm-fixed-price delivery order is for the supply of POMALYST 2 MG CAPSULE 21S, a prescription medication. The contract has an ultimate completion date of May 13, 2024. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,556,781,412 units of the pharmaceutical product POMALYST 3 MG CAPSULE 100S. The $162,093.60 contract was awarded on April 4, 2022 with a completion date of April 25, 2022. Amerisourcebergen Drug Corp, which has an existing indefinite delivery contract with the Department of Justice Federal...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $4,251.31 to AmerisourceBergen Drug Corp on August 4, 2025, with an ultimate completion date of August 29, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitively awarded contract for pharmaceutical and medical supply products. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the prime contractor and is performing work at its...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $1,976.34 to AmerisourceBergen Drug Corp on August 16, 2025, with an ultimate completion date of August 18, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the prime contractor under its existing contract vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this...
- The U.S. Defense Logistics Agency's Medical Supply Chain issued a delivery order valued at $1,063.72 to AmerisourceBergen Drug Corp on August 9, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitive award to the prime contractor under its larger indefinite delivery contract vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $4,049.10 to AmerisourceBergen Drug Corp on August 18, 2025, with an ultimate completion date of August 19, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitively awarded procurement supporting federal medical supply needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $4,038.72 to AmerisourceBergen Drug Corp on August 4, 2025, with an ultimate completion date of August 5, 2025. This firm fixed-price delivery order was awarded without a set-aside designation through competitive procurement and is being performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger...